- home
- article
- Purdue Pharma Owners Agree to Pay $7.4 Billion in Opioid Settlements
Purdue Pharma Owners Agree to Pay $7.4 Billion in Opioid Settlements
ai generated text
Purdue Pharma, the manufacturer of the prescription painkiller OxyContin, has agreed to a settlement of up to $7.4 billion to end lawsuits related to the drug's role in the opioid epidemic. The amount is an increase of over $1 billion from a previous settlement rejected by the US Supreme Court in 2024. The deal, announced on Thursday, would fund support for opioid addiction treatment and prevention across the US, with the Sackler family, who own the company, contributing to the settlement. This settlement is one of the largest to be reached over the past several years. The Supreme Court had blocked an earlier, $6 billion multistate agreement that would have protected the Sacklers from civil lawsuits.
The Sackler family relentlessly pursued profit at the expense of vulnerable patients and played a critical role in starting and fuelling the opioid epidemic.
The Sacklers no longer have control of Purdue and will never be allowed to sell opioids in the United States again.
There is not enough money in the world to make it right.
We are extremely pleased that a new agreement has been reached that will deliver billions of dollars to compensate victims, abate the opioid crisis, and deliver treatment and overdose rescue medicines that will save lives.
Everything in my life is shaped by a company that put profits over human lives.
US Opioid Crisis
- McKinsey to Pay $650 Million to Settle US Opioid Marketing Case
- US Supreme Court Rejects Opioid Settlement Shielding Sackler Family
- Walgreens and CVS offer to pay more than $10 billion to settle opioid lawsuits
sources
perspectives
- 1.Lawsuit
- 2.Healthcare
- 3.Opiods